Search
-
Building reputation in 2023: the link between corporate reputation and business efficiency
Drawing on new data from our latest 24-country Global Reputation Monitor, this paper explores the relationship between a good reputation and better business efficiency.
-
Doing Well by Doing Good: Resilience, Risk and the Reputation Value of ESG
ESG creates opportunity, in particular, it helps to drive innovation. Its ‘sustainability lens’ forces businesses to think critically about the long-term value they create, and to identify new trends, business opportunities and partnerships. More broadly, ESG is an increasingly powerful tool to strengthen corporate reputations.
-
ESG – a time for leadership, focus and communication, but above all action
Concluding from the latest Ipsos ESG Council report, it's increasingly clear ESG's role as an agent for positive change.
-
30 Major Future Challenges in Evidence, Pricing & Access and How to Overcome Them
Discover the 30 major Market Access challenges that will need to be overcome if, in a healthcare world that is evolving rapidly, real world outcomes are to meet the theoretical promises.
-
Navigating Social Issues: When and how to speak out
Five pieces of actionable guidance for corporate communication leaders as they determine what to speak out on and how, with a focus on maximising opportunities and limiting risk.
-
Ipsos resumes face-to-face fieldwork
Following an extensive trial process, face-to-face fieldwork is back
-
Reputation resilience in the age of ‘fake news’
As the transmission of misinformation is faster and easier than ever before, the push to tackle it has been imbued with a new sense urgency. But in the meantime, what can businesses do to mitigate the risk fake news poses?
-
Bank branch closures: a communications conundrum
Bank branch closures remain a major issue for banks, with changing financial habits and the threat of new competitors set to exacerbate the problem in years ahead. So what should a bank consider before closing a branch, and how could it affect its reputation?
-
Ipsos Research Highlights - October 2018
Welcome to our review of October. This month saw a further fall in confidence in Theresa May, more concern about Brexit (only 29% think we'll get a deal), and support for more public spending and tax cuts in the Budget.
-
Patient-Centricity: Decoding The Buzzword
No matter how you slice it, pharmaceutical companies across the industry are scrambling to be perceived as putting the patient first. But who is making good on this? What more needs to be done?